Skip to main content

Larance, Briony Dr

VC Postdoctoral Senior Research Fellow

  • VC Postdoctoral Senior Research Fellow - School of Psychology, Faculty of Social Sciences, UOW 2018 -
  • Conjoint Senior Research Fellow, National Drug and Alcohol Research Centre - University of New South Wales 2019 -
  • Affiliate - Illawarra Health and Medical Research Institute 2019 -

Overview


Dr Larance is a Vice Chancellor’s  Postdoctoral Senior Research Fellow at the University of Wollongong, an Illawarra Health and Medical Research Institute affiliate, and a Conjoint Senior Research Fellow at NDARC, UNSW Sydney. She completed a NHMRC early career research fellowship (2014-2018) at NDARC examining the trajectories and health consequences of pharmaceutical opioid use.

Her research examines strategies to reduce the harms associated with illicit drug use, and effective treatments for substance use disorders. Her work intersects psychology, addiction medicine, pain medicine, psychiatry and public health. She applies innovative research methods, undertaking prospective cohort studies, clinical trials, post-marketing surveillance studies and analyses of linked administrative data to generate critical knowledge relevant to health policy and clinical practice.

Research Overview



  • Dr Larance's specific research interests include the use and extra-medical use of pharmaceutical opioids, 'abuse-deterrent' formulations, treatment of substance use disorders, opioid dependence, the use of anabolic steroids, and interventions to improve the health and wellbeing of people who inject drugs. Her current projects include: developing and validating an opioid-related behaviour scale; a prospective cohort study of people prescribed opioids for non-cancer pain; a post-marketing study of tapentadol; a mixed-methods study to increase the capacity of a Local Health District to respond to methamphetamine-related harm; a feasibility trial of a SMART Recovery app; and an implementation trial of long-acting (depot) buprenorphine for opioid dependence.

Available as Research Supervisor

Selected Publications


Impact Story


Available as Research Supervisor

Potential Supervision Topics


    • Substance use disorders and treatment
    • Opioid dependence
    • Mental health and substance use
    • Physical health and substance use
    • Disability, social inclusion and wellbeing
    Dr Larance is available to supervise Masters and PhD projects.

Keywords


  • opioids; heroin; opioid dependence; substance use disorders; methamphetamine; abuse deterrent formulations; anabolic steroids; performance and image enhancing drugs; people who inject drugs; methadone; buprenorphine; medication assisted treatment; help-seeking; alcohol and other drugs treatment

Mailing Address


  • Room 128a, Building 41

    Northfields Avenue

    Wollongong

    NSW

    2522

    Australia

Research Overview



  • Dr Larance's specific research interests include the use and extra-medical use of pharmaceutical opioids, 'abuse-deterrent' formulations, treatment of substance use disorders, opioid dependence, the use of anabolic steroids, and interventions to improve the health and wellbeing of people who inject drugs. Her current projects include: developing and validating an opioid-related behaviour scale; a prospective cohort study of people prescribed opioids for non-cancer pain; a post-marketing study of tapentadol; a mixed-methods study to increase the capacity of a Local Health District to respond to methamphetamine-related harm; a feasibility trial of a SMART Recovery app; and an implementation trial of long-acting (depot) buprenorphine for opioid dependence.

Selected Publications


Impact Story


Potential Supervision Topics


    • Substance use disorders and treatment
    • Opioid dependence
    • Mental health and substance use
    • Physical health and substance use
    • Disability, social inclusion and wellbeing
    Dr Larance is available to supervise Masters and PhD projects.

Keywords


  • opioids; heroin; opioid dependence; substance use disorders; methamphetamine; abuse deterrent formulations; anabolic steroids; performance and image enhancing drugs; people who inject drugs; methadone; buprenorphine; medication assisted treatment; help-seeking; alcohol and other drugs treatment

Mailing Address


  • Room 128a, Building 41

    Northfields Avenue

    Wollongong

    NSW

    2522

    Australia